FDA Adverse Event Injury Summary report: N

GORE® CARDIOFORM ASD OCCLUDER

MDR report key: 9152538 · Received October 3, 2019

Report

Report Number
2017233-2019-00980
Event Type
Injury
Date Received
October 3, 2019
Date of Event
September 10, 2019
Report Date
October 14, 2019
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MLV
UDI-DI
00733132636518
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

H.6. RESULTS CODE 1: CORRECTED FROM 3221 TO 213. A REVIEW OF THE MANUFACTURING RECORDS VERIFIED THE LOT WAS PROCESSED NORMALLY AND ALL PRE-RELEASE SPECIFICATIONS WERE MET.

Additional Manufacturer Narrative · 0

ADDED H.6. DEVICE CODE 1: 3026.

Additional Manufacturer Narrative · 1

PMA/510(K) #: P050006. (B)(4). THE GORE® CARDIOFORM ASD OCCLUDER INSTRUCTIONS FOR USE NOTE THAT REMOVAL OF THE OCCLUDER SHOULD BE CONSIDERED IF THE SELECTED OCCLUDER ALLOWS EXCESSIVE SHUNTING.

Description of Event or Problem · 1

IT WAS REPORTED THE PHYSICIAN IMPLANTED A 44 MM GORE® CARDIOFORM ASD OCCLUDER TO CLOSE AN ATRIAL SEPTAL DEFECT BALLOON SIZED TO 26 MM. THE EVENING OF THE PROCEDURE AN ECHOCARDIOGRAM SHOWED A RESIDUAL SHUNT THAT WAS NOT SEEN FOLLOWING DEVICE IMPLANT. THE PHYSICIAN REMOVED THE DEVICE IN A TRANSCATHETER PROCEDURE. THE DEFECT WAS NOT CLOSED AND THE PATIENT WILL LIKELY BE SENT TO SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
948119 GORE® CARDIOFORM ASD OCCLUDER TRANSCATHETER, SEPTAL OCCLUDER MLV W.L. GORE & ASSOCIATES 18481001A 00733132636518

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| O